EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles

Jaeyoon Chung, Nathan Sahelijo, Toru Maruyama, Junming Hu, Rebecca Panitch, Weiming Xia, Jesse Mez, Thor D Stein, Alzheimer's Disease Neuroimaging Initiative, Andrew J Saykin, Haruko Takeyama, Lindsay A Farrer und 3 weitere

Alzheimer's & Dementia · 2023-11 · 19 (11) · 5173-5184

DOI: 10.1002/alz.13069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 11.05.2023. Verfasst von Jaeyoon Chung und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alzheimer's disease (AD) is heterogeneous, both clinically and neuropathologically. We investigated whether polygenic risk scores (PRSs) integrated with transcriptome profiles from AD brains can explain AD clinical heterogeneity.

Methods

We conducted co‐expression network analysis and identified gene sets (modules) that were preserved in three AD transcriptome datasets and associated with AD‐related neuropathological traits including neuritic plaques (NPs) and neurofibrillary tangles (NFTs). We computed the module‐based PRSs (mbPRSs) for each module and tested associations with mbPRSs for cognitive test scores, cognitively defined AD subgroups, and brain imaging data.

Results

Of the modules significantly associated with NPs and/or NFTs, the mbPRSs from two modules (M6 and M9) showed distinct associations with language and visuospatial functioning, respectively. They matched clinical subtypes and brain atrophy at specific regions.

Discussion

Our findings demonstrate that polygenic profiling based on co‐expressed gene sets can explain heterogeneity in AD patients, enabling genetically informed patient stratification and precision medicine in AD. HIGHLIGHTS Co‐expression gene‐network analysis in Alzheimer's disease (AD) brains identified gene sets (modules) associated with AD heterogeneity. AD‐associated modules were selected when genes in each module were enriched for neuritic plaques and neurofibrillary tangles. Polygenic risk scores from two selected modules were linked to the matching cognitively defined AD subgroups (language and visuospatial subgroups). Polygenic risk scores from the two modules were associated with cognitive performance in language and visuospatial domains and the associations were confirmed in regional‐specific brain atrophy data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansTranscriptomePlaque, AmyloidBrainRisk FactorsAtrophy

Stichwörter der Autor:innen

Alzheimer's diseaseco-expression networkcognitive performancegenetic subtypingmodule-based polygenic risk scorepatient stratificationprecision medicine

Autor:innen und Institutionen

  • Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts, USA.
  • Department of Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.
  • Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Department of Veterans Affairs Medical Center, Bedford, Massachusetts, USA.
  • Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Department of Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute on Aging

Zitieren

APA

Chung, J., Sahelijo, N., Maruyama, T., Hu, J., Panitch, R., Xia, W., Mez, J., Stein, T. D., Alzheimer's Disease Neuroimaging Initiative, Saykin, A. J., Takeyama, H., Farrer, L. A., Crane, P. K., Nho, K., & Jun, G. R. (2023). Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles. Alzheimer's & Dementia, 19(11), 5173-5184. https://doi.org/10.1002/alz.13069

Vancouver

Chung J, Sahelijo N, Maruyama T, Hu J, Panitch R, Xia W, et al. Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles. Alzheimer's & Dementia. 2023;19(11):5173-5184. doi:10.1002/alz.13069

BibTeX
@article{Chung2023,
  author = {Chung, Jaeyoon and Sahelijo, Nathan and Maruyama, Toru and Hu, Junming and Panitch, Rebecca and Xia, Weiming and Mez, Jesse and Stein, Thor D and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Saykin, Andrew J and Takeyama, Haruko and Farrer, Lindsay A and Crane, Paul K and Nho, Kwangsik and Jun, Gyungah R},
  title = {Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {11},
  pages = {5173--5184},
  doi = {10.1002/alz.13069}
}
Kostenlos starten →